British American Tobacco p.l.c.
No SEC Form 4 filings for $BTI in the last 30 days.
See all $BTI insider activity →British American Tobacco p.l.c. disclosed that 770 shares were released to Regional Director Pascale Meulemeester under the Restricted Share Plan. 364 shares were sold to cover tax liabilities, totaling £15,216.61. The transactions occurred on 30 September 2026 outside a trading venue.
British American Tobacco (BTI) and Philip Morris (PM) are compared for retirement investors. PM has a higher dividend growth rate, better cash coverage, and stronger smoke-free product sales. BTI offers a higher yield but faces currency risks and slower growth. PM shares are up 21.91% YTD, while BTI is down 0.71%. PM's dividend yield is 3.03% with a payout of $6.40 annually. BTI's yield is higher but subject to exchange rate fluctuations.
British American Tobacco (BAT) anticipates mid-teens annual revenue growth from smoking alternatives until 2030, driven by nicotine pouches, with industry revenues expected to grow 4% from 2025-2030. BAT predicts nicotine pouch revenues will triple, with a 30% contribution margin by 2030. The company also expects global tobacco volumes to decline 2.5% in the same period and remains on track to meet its 2026 financial guidance.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning BTI (British American Tobacco p.l.c.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent BTI coverage spans earnings, regulation and financial news.
Small insider transaction likely has minimal price impact.
Modest dividend raise may be outweighed by currency‑risk concerns for U.S. investors.
Guidance upgrade may lift BTI shares as investors price higher future margins.
Guidance is modest and shares fell 1.1% pre‑market, suggesting investors may price in downside pressure.
Guidance below prior expectations may pressure the stock.
AlphAI scores every news story that mentions BTI with an AI model for sentiment and relevance, and aggregates insider trades from British American Tobacco p.l.c.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
British American Tobacco p.l.c. disclosed that 770 shares were released to Regional Director Pascale Meulemeester under the Restricted Share Plan. 364 shares were sold to cover tax liabilities, totaling £15,216.61. The transactions occurred on 30 September 2026 outside a trading venue.
1 min readBritish American Tobacco (BTI) and Philip Morris (PM) are compared for retirement investors. PM has a higher dividend growth rate, better cash coverage, and stronger smoke-free product sales. BTI offers a higher yield but faces currency risks and slower growth. PM shares are up 21.91% YTD, while BTI is down 0.71%. PM's dividend yield is 3.03% with a payout of $6.40 annually. BTI's yield is higher but subject to exchange rate fluctuations.
2 min readBritish American Tobacco (BAT) anticipates mid-teens annual revenue growth from smoking alternatives until 2030, driven by nicotine pouches, with industry revenues expected to grow 4% from 2025-2030. BAT predicts nicotine pouch revenues will triple, with a 30% contribution margin by 2030. The company also expects global tobacco volumes to decline 2.5% in the same period and remains on track to meet its 2026 financial guidance.
2 min readBritish American Tobacco (BTI) outlined growth targets at its Capital Markets Day, aiming for mid-teens revenue growth in new product categories by 2030. The company projects 3-5% revenue growth for 2026 and maintains a 5.93% dividend yield with a 41% payout ratio. BTI's shares are currently 34.1% overvalued according to GuruFocus' GF Value™ estimate.
3 min readBritish American Tobacco (BAT) expects FY26 revenue growth at the lower end of its 3-5% guidance range. The company aims for mid-teens New Category revenue growth and a 30% contribution margin by 2030. BAT also anticipates a 2-2.5% FX headwind on adjusted diluted EPS growth. The company hosted a Capital Markets Day to outline its Horizon 2030 ambitions.
2 min readBritish American Tobacco (BATS) shares dropped 1.7% after the company revised its 2026 growth outlook, expecting lower-end revenue (3-5%) and profit (4-6%) growth, and mid-range EPS growth (5-8%). The company also outlined its 2030 ambitions, aiming for mid-teens New Category revenue growth and a 30% contribution margin. BATS expects a 2-2.5% FX headwind on 2026 EPS growth.
2 min readThe FDA updated Import Alert 98-07 to include its May 2026 enforcement policy for unauthorized ENDS, affecting import detention procedures. The policy prioritizes enforcement based on product risk and application status. Examples include Charlie's Holdings' PACHA and R.J. Reynolds' Vuse Pro, neither of which gained marketing authorization. The revision maintains DWPE but adds Center for Tobacco Products review for certain cases.
2 min readThe Trump administration plans to speed up approvals for smoke-free nicotine products like vapes and nicotine pouches, easing FDA review requirements. This benefits tobacco companies such as Altria (MO), Philip Morris (PM), and British American Tobacco (BTI), which face regulatory delays. The move aims to reduce illegal products but faces opposition from health advocates concerned about youth access.
2 min readPhilip Morris (PM) has a consensus 'Moderate Buy' rating with a $206.43 price target, implying 6% upside. Altria Group (MO) gained 22% YTD, with a $69.58 consensus target. British American Tobacco (BTI) has a 22% upside target amid restructuring and smokeless product growth.
2 min readReynolds American, a subsidiary of British American Tobacco, has launched four new Vuse Pro vape pod flavors in the U.S. without FDA authorization. The FDA's May guidance allows this under specific conditions, but critics argue it may encourage noncompliance. Reynolds claims compliance with state regulations and has implemented youth access prevention measures. Youth vaping has declined to 5.9%, but adult vaping is rising. The FDA faces lawsuits over its enforcement policy and review process.
3 min read
